Dimensional Fund Advisors’s Janux Therapeutics JANX Stock Holding History

Dimensional Fund Advisors’s Portfolio JANX Stock Details JANX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.34M	Sell	96,630 -127,664	-57%	-$1.75M	﹤0.01%	2786
2025 Q4	$3.1M	Sell	224,294 -16,337	-7%	-$384K	﹤0.01%	2640
2025 Q3	$5.88M	Buy	240,631 +101,970	+74%	+$2.48M	﹤0.01%	2494
2025 Q2	$3.2M	Buy	138,661 +121,711	+718%	+$3.21M	﹤0.01%	2634
2025 Q1	$460K	Sell	16,950 -3,098	-15%	-$117K	﹤0.01%	3014
2024 Q4	$1.07M	Sell	20,048 -324	-2%	-$17.1K	﹤0.01%	2897
2024 Q3	$926K	Sell	20,372 -3,647	-15%	-$159K	﹤0.01%	2925
2024 Q2	$1M	Buy	24,019 +8,422	+54%	+$395K	﹤0.01%	2908
2024 Q1	$587K	Buy	+15,597	New	+$340K	﹤0.01%	3017

Other funds holding JANX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors's JANX Position: Q1 2026 in Review

Dimensional Fund Advisors reduced its Janux Therapeutics (JANX) stake by 57% in Q1 2026, selling an estimated $1.75M and leaving 96,630 shares worth $1.34M. The position accounts for ﹤0.01% of the portfolio, ranked #2786.

Dimensional Fund Advisors first reported a position in JANX in Q1 2024 and has held it in 9 quarters since. The position peaked at $5.88M in Q3 2025. 190 funds tracked by Wall St. Rank hold JANX as of Q1 2026.

Dimensional Fund Advisors held 96,630 shares of Janux Therapeutics worth $1.34M as of Q1 2026.
Dimensional Fund Advisors sold 127,664 Janux Therapeutics shares in Q1 2026, an estimated $1.75M.
Janux Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2786 holding.
Dimensional Fund Advisors first reported a position in Janux Therapeutics in Q1 2024 and has held it in 9 quarters since.
Dimensional Fund Advisors's Janux Therapeutics position peaked at $5.88M in Q3 2025.
190 funds tracked by Wall St. Rank held Janux Therapeutics as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.